A detailed history of Janus Henderson Group PLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 25,642 shares of CLDX stock, worth $692,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,642
Previous 25,642 -0.0%
Holding current value
$692,846
Previous $949,000 8.22%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$32.76 - $42.56 $9,172 - $11,916
-280 Reduced 1.08%
25,642 $949,000
Q1 2024

May 15, 2024

BUY
$35.22 - $51.88 $1,373 - $2,023
39 Added 0.15%
25,922 $1.09 Million
Q4 2023

Feb 14, 2024

BUY
$22.61 - $40.65 $200,392 - $360,280
8,863 Added 52.07%
25,883 $1.03 Million
Q2 2023

Aug 14, 2023

SELL
$30.29 - $38.28 $757 - $957
-25 Reduced 0.15%
17,020 $577,000
Q1 2023

May 15, 2023

BUY
$34.78 - $47.43 $311,663 - $425,020
8,961 Added 110.85%
17,045 $613,000
Q4 2022

Feb 14, 2023

BUY
$27.78 - $45.38 $224,573 - $366,851
8,084 New
8,084 $360,000
Q3 2022

Nov 14, 2022

BUY
$22.7 - $37.57 $476 - $788
21 Added 0.26%
8,083 $227,000
Q2 2022

Aug 15, 2022

SELL
$20.5 - $37.33 $389 - $709
-19 Reduced 0.24%
8,062 $217,000
Q1 2022

May 16, 2022

BUY
$27.64 - $39.32 $55 - $78
2 Added 0.02%
8,081 $275,000
Q4 2021

Feb 14, 2022

BUY
$35.68 - $56.27 $145,288 - $229,131
4,072 Added 101.62%
8,079 $312,000
Q3 2021

Nov 16, 2021

BUY
$28.95 - $55.99 $116,002 - $224,351
4,007 New
4,007 $216,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.26B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.